Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1

From Gilead:

Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1

- 33rd NASDAQ OMX Investor Program -

- Piper Jaffray 27th Annual Healthcare Conference -

- Webcasts Available Through Gilead Corporate Website -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 24, 2015-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts from two upcoming investor conferences: the 33rd NASDAQ OMX Investor Program in London and the Piper Jaffray 27th Annual Healthcare Conference in New York.

Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the NASDAQ conference on Tuesday, December 1 at 10:15 a.m. Greenwich Mean Time (5:15 a.m. Eastern Time).

Paul R. Carter, Gilead’s Executive Vice President, Commercial Operations, will participate in a fireside chat at the Piper Jaffray conference on Tuesday, December 1 at 9:30 a.m. Eastern Time.

The live webcast can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.